OR WAIT null SECS
November 03, 2023
Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
November 02, 2023
A novel approach for safety assessments in inhalation drugs may avoid animal testing for drug products.
May 19, 2023
Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.
March 17, 2023
Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.
January 03, 2023
Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.
September 03, 2022
It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.
May 03, 2022
Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions.
November 03, 2021
Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.
October 15, 2021
Experts share best practices in designing, manufacturing, and scaling up dry powder inhaler and metered dose inhaler drug–device combination products for inhalation drug delivery.
September 13, 2021
When designing and manufacturing a pMDI or DPI combination drug-delivery device, the commercial stage should be kept in mind from the beginning of development.